The Preclinical CRO Global Market Report 2023, provides comprehensive information on the preclinical CRO market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Preclinical CRO Market’s Growth:
https://www.thebusinessresearchcompany.com/report/preclinical-cro-global-market-report
As per The Business Research Company’s Preclinical CRO Global Market Report 2023, the market size is expected to grow from $4.67 billion in 2022 to $5.15 billion in 2023 at a compound annual growth rate (CAGR) of 10.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global preclinical CRO market size is expected to reach $7.26 billion in 2027 at a CAGR of 8.9%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=10303&type=smp
Technological advancements are a key trend gaining popularity in the preclinical CRO market. Major companies operating in the preclinical CRO market are adopting new technologies to sustain their position in the market. For instance, in February 2023, BenchSci, a Canada-based AI solutions company for preclinical R&D launched ASCEND, an end-to-end SaaS (software as a service) platform and for preclinical drug discovery. By gaining biological insights into the fundamental underpinnings of disease, this method seeks to speed up preclinical phase drug development pipelines. ASCEND extracts experimental data from safe internal and public external sources using BenchSci’s machine learning technology. The platform compares experimental results using curated ontology datasets. As a result, the software can produce a “map” of the biological processes underpinning various diseases that is based on evidence.
The preclinical CRO market is segmented:
1) By Service: Bioanalysis And DMPK Studies, Toxicology Testing, Compound Management, Chemistry, Safety Pharmacology, Others Services
2) By Type: Patient Derived Organoid (PDO) Model, Patient Derived Xenograft Model
3) By Animal Model: Small Animal Model, Large Animal Model
4) By Model System: In Vivo, In Vitro
5) By End User: Biopharmaceutical Companies, Government And Academic Institutes, Medical Device Companies, Other End-users
North America was the largest region in the preclinical CRO market in 2022.
The table of contents in TBRC’s preclinical CRO market report includes:
1. Executive Summary
2. Preclinical CRO Market Characteristics
3. Preclinical CRO Market Trends And Strategies
4. Preclinical CRO Market – Macro Economic Scenario
5. Preclinical CRO Market Segmentation
.
.
.
26. Africa Preclinical CRO Market
27. Preclinical CRO Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Preclinical CRO Market
29. Preclinical CRO Market Future Outlook and Potential Analysis
30. Appendix
Top Major Players:
- Eurofins Scientific SE
- PRA Health Sciences Inc.
- Wuxi AppTec
- Medpace Inc
- Charles River Laboratories International Inc
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
